Prior COVID-19 infection and fibromyalgia criteria fulfillment: a comparative cross-sectional study
Frontiers in Medicine · 07.08.2026 · 13
DOI: 10.3389/fmed.2026.1876965 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Medicine, online erschienen am 07.08.2026. Verfasst von Mustafa Alhayali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fibromyalgia (FM) is a chronic widespread pain syndrome frequently accompanied by fatigue, cognitive dysfunction, psychological symptoms, and multiple somatic symptoms. Coronavirus disease 2019 (COVID-19) has affected millions worldwide; however, its long-term sequelae remain incompletely understood.
Objective
This study aimed to investigate whether prior COVID-19 infection was associated with a higher prevalence of fibromyalgia and to identify demographic and clinical factors associated with fibromyalgia in the study population. Subjects and methods This comparative cross-sectional study included 250 individuals with PCR-confirmed COVID-19 at least 3 months before assessment and 250 participants without a known history of confirmed COVID-19 infection. Data were collected at a single time point using a structured questionnaire and interview. Fibromyalgia status was defined as fulfillment of the modified 2016 American College of Rheumatology criteria.
Results
Fibromyalgia criteria were fulfilled by 60/250 participants (24.0%) with prior COVID-19 infection compared with 35/250 participants (14.0%) in the comparison group. In crude analysis, prior COVID-19 infection was associated with higher odds of fibromyalgia criteria fulfillment (OR = 1.94, 95% CI: 1.22–3.07, p = 0.004). After adjustment for age group, sex, educational level, occupation, smoking status, and chronic disease, prior COVID-19 infection remained significantly associated with higher odds of fibromyalgia criteria fulfillment (adjusted OR = 2.18, 95% CI: 1.33–3.58, p = 0.002).
Conclusion
Prior COVID-19 infection remained associated with higher odds of modified 2016 ACR fibromyalgia criteria fulfillment. Female sex and non-employment were also associated with fibromyalgia criteria fulfillment, highlighting the need for clinical awareness and early recognition of fibromyalgia-like symptoms among individuals with a history of COVID-19 infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology, Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq.
- Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.
- Faculty of Medicine, An-Najah National University, Nablus, Palestine.
- College of Medicine, University of Baghdad, Baghdad, Iraq.
- Faculty of Medicine, University of Bahri, Khartoum, Sudan.
- Internal Medicine Department, Aldujail Hospital, Salahaldin, Iraq.
Zitieren
APA
Alhayali, M., Salman, S., Shahrori, M. A., Ahmed Shimal, A., Ahmed, M. J., Al-Mashhadani, M., Shukur, Z., Alfirtusi, N., & Al-Obaidi, A. D. (2026). Prior COVID-19 infection and fibromyalgia criteria fulfillment: a comparative cross-sectional study. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1876965
Vancouver
Alhayali M, Salman S, Shahrori MA, Ahmed Shimal A, Ahmed MJ, Al-Mashhadani M, et al. Prior COVID-19 infection and fibromyalgia criteria fulfillment: a comparative cross-sectional study. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1876965
BibTeX
@article{Alhayali2026,
author = {Alhayali, Mustafa and Salman, Sami and Shahrori, Mustafa A and Ahmed Shimal, Aya and Ahmed, Marafi Jammaa and Al-Mashhadani, Marwah and Shukur, Zainab and Alfirtusi, Noor and Al-Obaidi, Ahmed Dheyaa},
title = {Prior COVID-19 infection and fibromyalgia criteria fulfillment: a comparative cross-sectional study},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1876965}
}
EUVIMED